$0.37 5.1%
CUTR Stock Price vs. AI Score
Data gathered: December 9

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Cutera (CUTR)

Analysis generated January 9, 2024. Powered by Chat GPT.

Cutera is a company that operates in the medical devices industry, specializing in laser and energy-based aesthetic systems for practitioners worldwide. Their portfolio of products is designed to enhance a wide range of treatments, including hair removal, skin rejuvenation, vascular conditions, and body contouring. Recognized for their innovative technology, Cutera's commitment to delivering high-quality solutions is evident in their continuous research and development efforts. As a company that serves a market with a significant focus on aesthetics, Cutera benefits from recurring revenue from consumables and a business model that is scalable across different regions.

Read full AI stock Analysis

Stock Alerts - Cutera (CUTR)

company logo Cutera | December 9
Price is down by -5.1% in the last 24h.
company logo Cutera | December 6
Price is up by 6% in the last 24h.
company logo Cutera | December 5
Price is down by -6.7% in the last 24h.
company logo Cutera | December 3
Price is up by 8.5% in the last 24h.

About Cutera

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide.


Cutera
Price $0.37
Target Price Sign up
Volume 187,300
Market Cap $7.9M
Year Range $0.29 - $2.86
Dividend Yield 0%
Analyst Rating 50% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2433M65M1.8M-39M-35M-1.670
Q2 '2434M52M7.6M-25M-21M-1.200
Q1 '2436M65M12M-23M-18M-0.700
Q4 '2350M105M-13M-57M-51M-1.350
Q3 '2344M83M6.5M-44M-41M-1.610

Insider Transactions View All

Karavitis Michael filed to sell 24,940 shares at $2.7.
May 16 '24
Karavitis Michael filed to sell 52,755 shares at $2.5.
May 16 '24
Drummond Stuart filed to buy 19,678 shares at $9.8.
August 30 '23
Harris Taylor C. filed to buy 279,336 shares at $9.9.
August 30 '23

What is the Market Cap of Cutera?

The Market Cap of Cutera is $7.9M.

What is the current stock price of Cutera?

Currently, the price of one share of Cutera stock is $0.37.

How can I analyze the CUTR stock price chart for investment decisions?

The CUTR stock price chart above provides a comprehensive visual representation of Cutera's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cutera shares. Our platform offers an up-to-date CUTR stock price chart, along with technical data analysis and alternative data insights.

Does CUTR offer dividends to its shareholders?

As of our latest update, Cutera (CUTR) does not offer dividends to its shareholders. Investors interested in Cutera should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Cutera?

Some of the similar stocks of Cutera are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.